Actinium Pharmaceuticals, Inc Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 74.90. In total, the insiders bought 14 809 883 and sold 57 212 ATNM shares in the last 100 trades.

Insider Power

(Last 100 transactions)
74.90
Buy 14 809 883 Shares
Sell 57 212 Shares

Historical Insider Trades

Date Type Action Person Amount
Dec 28, 2023 Stock Option (Right to Buy) Buy Nicholson, C. David 70 311
Dec 28, 2023 Stock Option (Right to Buy) Buy Steinhart Richard I 70 311
Dec 28, 2023 Stock Option (Right to Buy) Buy O'loughlin Steve 253 123
Dec 28, 2023 Stock Option (Right to Buy) Buy Shetty Ajit 70 311
Dec 28, 2023 Stock Option (Right to Buy) Buy Seth Sandesh 984 367
Dec 28, 2023 Stock Option (Right to Buy) Buy Chell Jeffrey W. 70 311
Aug 17, 2022 Common Stock Buy Seth Sandesh 300 000
Jul 01, 2022 Stock Option (Right to Buy) Buy O'loughlin Steve 256 438
Jul 01, 2022 Stock Option (Right to Buy) Buy O'loughlin Steve 256 438
Jul 01, 2022 Stock Option (Right to Buy) Buy Nicholson, C. David 72 156
Jul 01, 2022 Stock Option (Right to Buy) Buy Nicholson, C. David 72 156
Jul 01, 2022 Stock Option (Right to Buy) Buy Steinhart Richard I 72 156
Jul 01, 2022 Stock Option (Right to Buy) Buy Steinhart Richard I 72 156
Jul 01, 2022 Stock Option (Right to Buy) Buy Shetty Ajit 72 156
Jul 01, 2022 Stock Option (Right to Buy) Buy Seth Sandesh 827 366
Jul 01, 2022 Stock Option (Right to Buy) Buy Seth Sandesh 827 366
Jul 01, 2022 Stock Option (Right to Buy) Buy Chell Jeffrey W. 72 156
Sep 01, 2021 Stock Option (Right to Buy) Buy Chell Jeffrey W. 18 351
Sep 01, 2021 Stock Option (Right to Buy) Buy Berger Mark Stanley 67 164
Sep 01, 2021 Stock Option (Right to Buy) Buy Shetty Ajit 18 351
Sep 01, 2021 Stock Option (Right to Buy) Buy O'loughlin Steve 107 463
Sep 01, 2021 Stock Option (Right to Buy) Buy Steinhart Richard I 18 351
Sep 01, 2021 Stock Option (Right to Buy) Buy Seth Sandesh 310 182
Sep 01, 2021 Stock Option (Right to Buy) Buy Nicholson, C. David 18 351
Aug 12, 2020 Stock Option (Right to Buy) Buy O'loughlin Steve 59 066
Click to get the best stock tips daily for free!

About Actinium Pharmaceuticals, Inc

Actinium Pharmaceuticals Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19... ATNM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT